Spots Global Cancer Trial Database for autologous stem cell transplant (asct)
Every month we try and update this database with for autologous stem cell transplant (asct) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Tinostamustine Conditioning and Autologous Stem Cell | NCT03687125 | Multiple Myelom... Multiple Myelom... Multiple Myelom... | Tinostamustine Autologous Stem... | 18 Years - 75 Years | Mundipharma-EDO GmbH | |
| 2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT) | NCT03003728 | Multiple Myelom... | Elotuzumab Melphalan Autologous Stem... Expanded Natura... ALT-803 | 18 Years - 75 Years | University of Arkansas | |
| Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma | NCT03713580 | Non-hodgkin Lym... | Venetoclax | 18 Years - | Case Comprehensive Cancer Center | |
| A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma | NCT04268498 | Multiple Myelom... | Bortezomib Dexamethasone Lenalidomide Acetaminophen Diphenhydramine Montelukast Carfilzomib Daratumumab Autologous Stem... | 18 Years - 75 Years | University of Miami | |
| Carfilzomib/Cyclophosphamide/Dexamethasone With Maintenance Carfilzomib in Multiple Myeloma | NCT02315716 | Multiple Myelom... | Autologous Stem... Consolidation w... | 18 Years - | University College, London | |
| WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation | NCT01827137 | Multiple Myelom... Minimal Residua... High-Risk Cance... | WT1 Analog Pept... Sargramostim (G... lenalidomide | 18 Years - | Sellas Life Sciences Group | |
| Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas | NCT05681195 | Primary Central... Secondary Centr... Relapsed Cancer Refractory Canc... | Pemetrexed Zanubrutinib Autologous Stem... Whole Brain Rad... | 18 Years - | Baptist Health South Florida | |
| A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation | NCT02112045 | Multiple Myelom... | Granix High dose melph... Autologous Stem... | 18 Years - | Washington University School of Medicine | |
| Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma | NCT03713580 | Non-hodgkin Lym... | Venetoclax | 18 Years - | Case Comprehensive Cancer Center | |
| Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients | NCT04802356 | Multiple Myelom... | Belantamab mafo... Bortezomib Lenalidomide Dexamethasone Autologous stem... | 18 Years - | PETHEMA Foundation | |
| Tinostamustine Conditioning and Autologous Stem Cell | NCT03687125 | Multiple Myelom... Multiple Myelom... Multiple Myelom... | Tinostamustine Autologous Stem... | 18 Years - 75 Years | Mundipharma-EDO GmbH | |
| Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas | NCT05681195 | Primary Central... Secondary Centr... Relapsed Cancer Refractory Canc... | Pemetrexed Zanubrutinib Autologous Stem... Whole Brain Rad... | 18 Years - | Baptist Health South Florida | |
| A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma | NCT04268498 | Multiple Myelom... | Bortezomib Dexamethasone Lenalidomide Acetaminophen Diphenhydramine Montelukast Carfilzomib Daratumumab Autologous Stem... | 18 Years - 75 Years | University of Miami | |
| Velcade (Bortezomib) Consolidation After Transplant | NCT01539083 | Multiple Myelom... | Thalidomide Bortezomib Cyclophosphamid... Dexamethasone Prednisolone | 18 Years - | Janssen Scientific Affairs, LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
